Department of Biopharmaceutical Sciences

College of Pharmacy

Seminars Spring 2004

Spring 2004 Seminar Series
Department of Biopharmaceutical Sciences

College of Pharmacy Building (PHAR)
833 South Wood Street
Chicago, IL 60612

Date Time Room Speaker Name Affiliation Talk Title Host
1/21 3:30 PHAR 134-1 Ka Yee Lee, Ph.D. The University of Chicago Lipid-Protein Interactions at Interfaces: From Lung Surfactant to Poloxamer Gemeinhart
1/28 3:30 PHAR 134-1 Christine Moore, Ph.D. United States Drug Testing Laboratories, Inc Bio-markers for Alcohol Use and Abuse Negrusz
1/30 12:30 PHAR 134-1 William E. Evans, Pharm.D. St. Jude Children's Research Hospital Pharmacogenomics of Acute Lymphoblastic Leukemia Beck
2/4 3:30 PHAR 134-1 Henry Kopecek, Ph.D. University of Utah Macromolecular Therapeutics as Anticancer Agents Gemeinhart
2/11 3:30 PHAR 134-1 Robert Straubinger, Ph.D. University of Buffalo Liposome-Based Therapy of a Taxame-Resistant Brain Tumor Model Beck
2/18 3:30 PHAR 134-1 Rachel Ee
(Student Seminar)
University of Illinois at Chicago Regulation of ATP-Binding Cassette (ABC) Proteins Beck
2/25 3:30 PHAR 134-1 Milan Mrksich, Ph.D. The University of Chicago Engineering Bioactive Interfaces: Applications to Cell Biology and Drug Discovery Gemeinhart
3/3 3:30 PHAR 134-1 Victor Levenson, M.D. Northwestern University Molecular diagnosis of cancer Tonetti
3/10 10:00 PHAR 134-1 Otilia Koo
(Student Seminar)
University of Illinois at Chicago Delivery of Camptothecin in Nano-sized Phospholipid Micelles Onyuksel
3/17 3:30 PHAR 134-1 Scott H. Kaufmann, M.D., Ph.D. Mayo Clinic Topoisomerase I Poisons and the Response to DNA Damage Beck
4/7 3:30 PHAR 134-1 Marsha R. Rosner, Ph.D. The University of Chicago Regulation of Cell Signaling by MAP kinases Gemeinhart
4/9 3:30 PHAR 134-3 Chien Ma (Dissertation Defense) University of Illinois at Chicago Nadolol: Mechanism of Oral Absorption and its Implications in Drug Interactions Chiou
4/14 3:30 PHAR 134-1 Paul Dent, Ph.D. University of Virginia Cell Biology, Experimental Therapeutics and Cell Signaling: Hunting Down Adaptive Cancer Cells Miele
4/21 3:30 PHAR 134-1 Steven Boxer, Ph.D. Stanford University Patterned bilayers and tethered vesicles: tools for membrane biology Gemeinhart
4/28 3:30 PHAR 134-2 Susan P.C. Cole, Ph.D. Queen's University Complex Role of Proline Residues in the Structure and Function of the Drug and Organic Anion Transporter, MRP1 Beck
4/30 2:00 PHAR 32 Carol Kirchoff (Dissertation Defense) University of Illinois at Chicago Stabilization of proteins as aqueous solutions with the use of pegylated phospholipids Onyuksel
5/5 3:30 PHAR 32 William Plunkett, Ph.D. M.D. Anderson Cancer Center A Novel Trigger for the G2 Checkpoint Pathway Beck
5/7 10:30 PHAR 36 George Stark, Ph.D. Cleveland Clinic Novel Aspects of the Functions of STAT3, NFkB and p53 in Cancer Beck
5/10 3:30 PHAR 32 Luis Padilla, Ph.D. University of New Mexico Topoisomerase I Inhibitors: A successful therapeutic target in cervical cancer Beck
5/12 10:30 PHAR 36 Joe Balthasar, Ph.D. University of Buffalo Inverse targeting for the optimization of intraperitoneal chemotherapy Gemeinhart